NEW YORK (GenomeWeb News) — AutoGenomics has hauled in $12 million through a Series C round of private-equity financing from non-institutional investors, the company said today.
 
President Fareed Kureshy said the company will use the cash to “extend our test application menu, expand manufacturing and increase our sales and marketing efforts” for its Infiniti film-based microarray system.
 
The assays are designed to help diagnose clotting disorder thrombophilia.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.